Background: Stem cell-based therapy is a new method for the treatment of neurodegenerative diseases such as multiple sclerosis (MS). Human adipose-derived stem cells (hADSCs) are a kind of adult stem cells which have a higher frequency in the fat tissue and have the ability to differentiate into other cell types outside their lineage. Due to some serious adverse events of cell-based therapy such as tumorigenic potential, the aim of this study was to evaluate of hADSCs differentiation into oligodendrocytes as a valuable way for future cell transplantation. Methods: hADSC were isolated from lipoaspirate samples of human abdominal fat. After hADSC characterization via flow cytometry, the cells were induced to oligodendrocytes using a special differentiation medium. Finally, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), immunocytochemistry, and real-time polymerase chain reaction (RT-PCR) techniques were used for the evaluation of differentiated cells.
Introduction
Cell-based treatment is a novel idea for the treatment of demyelinating diseases such as multiple sclerosis (MS). The conclusive purpose of this strategy is the cell substitution and upregulation of neurotropic factors as well as
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http://ijnl.tums.ac.ir 5 January downregulation of apoptotic agents. MS is one of the most common autoimmune dysmyelinating disorders in central nervous system (CNS) which affects men more than women (sex ratio of 2.5:1). 1, 2 The use of disease-modifying drugs cannot prevent MS progression. 3, 4 So, stem cell-base therapy is proposed to provide a cure for MS. [5] [6] [7] In recent studies, human embryonic stem cells, human bone-marrow-derived mesenchymal stem cells (BM-MSCs), and human placental mesenchymal stem cells were transplanted in animal model of MS. 8, 9 Despite the efficiency of stem cell transplantation, serious side effects which may occur following the stem cell transplantation (such as tumorigenesis) cannot be denied. 10 Therefore, the use of fully differentiated cells instead of stem cells is a necessity. Laboratory studies proven that human Wharton's jelly stem cells (hWJ-SCs) and human dental pulp stem cells (DPSCs) are able to differentiate into other cells outside of their lineage such as oligodendrocyte progenitor cells. 11, 12 In addition, these cells, when transplanted in animal model of MS, are able to promote the regeneration of myelin sheaths, and significantly reduce the clinical signs of MS.
Since the frequency of hWJ-SCs-, DPSCs-, and BM-MSCs in-related tissue is low, and the isolation of these cells is a difficult process, many researchers have paid special attention to human adipose-derived stem cells (hADSCs).
hADSCs are specie of adult stem cells which have particular features including immunomodulatory and neuroprotective effects. In addition, these cells are able to differentiate into other cells in the body as well as a potency to generate many identified neurotrophic agents such as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and glial cell line-derived neurotrophic factor (GDNF). 5, 13 Meanwhile, some studies demonstrated that hADSCs are able to cross the blood-brain barrier and exert their action. 5, 6 Collectively, available data suggest that if hADSCs have the ability to differentiate into oligodendrocyte cells, these cells can be used as an ideal source of stem cells for MS treatment. Thus, the aim of this in-vitro study was to evaluate hADSCs differentiation into oligodendrocyte cells in order to access a valuable cell source for cell-based treatment in MS disease.
Materials and Methods
Stem cell isolation and culture: All procedures used in this study were approved by the Ethics Committee of Isfahan University of Medical Sciences, Isfahan, Iran (ethics code: 194267). After getting informed consent from healthy female donors (age range of 20-40 years) who referred to Alzahra hospital (Isfahan) for cesarean surgery, hADSCs were harvested from abdominal fat, and cultured according to our previous study. 5 Briefly, after washing with phosphate-buffered saline (PBS) (Sigma-Aldrich, UK), the samples were treated with 0.075% collagenase type I (Sigma-Aldrich, UK) for enzymatic degradation. In the following, the enzyme activity was neutralized with Dulbecco's Modified Eagles Medium (DMEM/F12) (Gibco, UK) contained 10% fetal bovine serum (FBS) (Gibco, UK), and then centrifuged for 10 minutes. Finally, the cell pellet was resuspended in DMEM/F12, 10% FBS, and 1% penicillin/streptomycin solution, and was cultured under standard conditions. Flow cytometry and cell characterization : For this purpose, 1 × 10 6 hADSCs (within 3 passages) were fixed in 2% paraformaldehyde (Sigma-Aldrich, UK) for 25 minutes, and after washing with PBS, the samples were incubated with respective fluorochrome-conjugated antibodies against CD105, CD49, CD31, and CD45 (Chemicon, Temecula, CA, USA) for 30 minutes. In addition, nonspecific fluorescein isothiocyanate (FITC)-conjugated immunoglobulin G (IgG) was used for isotype control. After incubation, the cells were washed and resuspended in PBS. Finally, the percentage of fluorescent cells was analyzed using a flow cytometer (Becton Dickinson, San Jose, CA, USA).
Induction of hADSCs into oligodendrocyte progenitor cells: According to our previous protocol, 14,15 1 × 10 4 hADSCs/cm 2 in the fifth passage were seeded into cell culture special plates, and cultured in present of DMEM/F12 which supplemented with 10 µl/ml N 2 (Gibco, UK), 10 ng/ml human recombinant epidermal growth factor (EGF) (Biolegend, UK), and penicillin/streptomycin (SPN Solutions, Tysons Corner, VA, USA) in standard incubator for 3 days. After this time, trypsinethylenediaminetetraacetic acid (EDTA) solution (0.25%-0.02%) was used to detach the cells from the wells. Then, the cells were plated in plastic dish at a density of 2 × 10 2 cells/cm 2 in presence of neurobasal medium (Life Technologies, UK) containing 20 ng/ml basic fibroblast growth factor (bFGF) (Pepro Tech, UK), B27 2% (Gibco, http://ijnl.tums.ac.ir 5 January UK), 20 ng/ml EGF (Pepro Tech, UK), 10 U/ml of penicillin, and 10 mg/ml streptomycin for 18 days. Finally, the cells in previous stage were cultured in 12 well tissue culture plates which coated with poly-L-Lysine (Sigma-Aldrich, UK) in a differentiation medium consisting of DMEM/F12, 1 × non-essential amino acids (NEAA) (Gibco, UK), L-glutamine (2 mM) (Gibco, UK), 1 × N 2 (Invitrogen, Carlsbad, CA, USA), 1 × B27 (Gibco, UK), sonic hedgehog (SHH: 200 ng/ml) (Sigma-Aldrich, UK), retinoic acid (2 µM) (Sigma-Aldrich, UK), in standard condition for 10 days and in second medium with DMEM/F12, 1 × NEAA, L-glutamine (2 mM), 1 × N 2 , 1 × B27, neurotrophin-3 (NT3) (30 ng/ml) (Biolegend, UK), and platelet-derived growth factor alpha (PDGFα) (10 ng/ml) (Biolegend, UK) for 2 weeks.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay: MTT assay was used for detection of cell viability before and after the final stage of cell differentiation. To this purpose, MTT solution (5 mg/ml) (Sigma-Aldrich, UK) was added to the hADSCs culture medium (control group) and to the differentiation medium (experimental group) at a dilution of 1:10 at 37 °C for 4 hours. Finally, the medium was replaced with 200 µl of dimethyl sulfoxide (DMSO) (SigmaAldrich, UK), and the absorbance of the solution in each well was detected using a microplate reader (Hiperion MPR 4+, Germany) at 540 nm.
Immunocytochemistry analysis for oligodendrocyte characterization: To evaluate differentiation of hADSCs into oligodendrocytes, the differentiated cells fixed first in 4% paraformaldehyde, and then cell permeabilized with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween. Then, the samples incubated with primary antibodies in humidified condition at 4 °C overnight. For this purpose, anti-A2B5 FITC antibody (1 µg/ml Abcam, Cambridge, MA, USA), anti-oligodendrocyte transcription factor (Olig2) FITC antibody (1:1000; Abcam, Cambridge, MA, USA), anti-myelin basic protein (MBP) FITC antibody (1:1000; Abcam, Cambridge, MA, USA), and anti-glial fibrillary acidic protein (GFAP) FITC antibody (1:1200; Abcam, Cambridge, MA, USA) were used. After cell washing with PBS, the samples were treated with goat anti-mouse FITC (1:500; Abcam, Cambridge, MA, USA)-conjugated secondary antibodies at room temperature for 1 hour and for 5 minutes with 4',6-diamidino-2-phenylindole (DAPI) in order to cell counting. Finally, the number of A2B5-, Olig2-, MBP-, and GFAPpositive cells were counted for a minimum of 200 cells per slide using fluorescence microscope (Olympus, BX51, Japan). Meanwhile, all immunocytochemistry studies were repeated at least twice, and undifferentiated hADSCs were used as the control sample.
Real-time polymerase chain reaction (RT-PCR):
At the end of differentiation procedure, the differentiated cells were subjected to real-time (SYBR Green) PCR. Briefly, total RNA was extracted from 1 × 10 5 differentiated cells and 1 × 10 5 undifferentiated cells using RNeasy micro Kit (Qiagen, Germany), and then cDNA synthesis was done with Revert Aid First Strand cDNA Synthesis Kit (Fermentas, Burlington, ON, Canada). Specific genes, including Olig2, plateletderived growth factor receptor alpha (PDGFRα), MBP, and astrocyte specific marker (GFAP), and a housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) relative expression analysis was done by Thermal Cycler Rotor-Gene. Meanwhile, real-time specific primer pairs which used in this study were shown in table 1. Data an software (v NY) using one-way an were presen mean (SEM considered showed th 9-positive, b Figure 2 http://ijnl.tums.ac.ir 5 January and a very low percent of them (1.0 ± 0.9 percent) expressed GFAP (astrocyte marker) which were significantly lower than Olig2 and A2B5 (P < 0.001). 
Results
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RT-PCR results:
After oligodendrocyte differentiation, total RNA extracted from differentiated cells in order to RT-PCR assay. To this end, GAPDH was used as a control marker. Our results revealed that the expression of Olig2 and PDGFRα markers were higher compare to MBP and GFAP markers which is consistent with our immunocytochemistry results. In addition, the mean expression level of Olig2 and PDGFRα genes increased significantly in differentiated cells in compared to control group ( Figure 6 ). Quantification was done in oligodendrocytes after normalization to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The mean expression level of oligodendrocyte transcription factor (Olig2) and PDGFRα genes increased significantly in differentiated cells in compared to control group. * P < 0.010, ** P < 0.001 18 hADSCs which are a kind of adult stem cells have several specific features. Due to the abundance and availability, these cells may be one of the ideal sources for stem cell therapy. 19 Previous studies have shown that hADSCs have the ability to differentiate into other cells of ectodermal, mesodermal, and endodermal lineage, and can promote cell differentiation and nerve protection via paracrine effects. 13, 20, 21 In present study, for the first time, hADSCs were differentiated into oligodendrocyte cells in order to access a valuable cell source for later cell transplantation in MS disease.
Discussion
Some species of stem cells such as hematopoietic stem cells are relatively more numerous in men than in women. 22 In addition, it has been reported that stem cells separated from the muscles of female mice are better at regenerating tissue than those taken from male mice. 23 In similar experiment, Ogawa, et al. reported that adipose derived stem cells (ADSCs) which isolated from female mice have more ability to differentiate into adipocytes than those taken from male mice. 24 Thus, it appears that the differentiation potential of ADSCs is closely related to sex differences. As a result, in this study, hADSCs were taken from healthy female donors, and then differentiated into oligodendrocyte progenitor cells.
A2B5 is a membrane epitope which typically express in oligodendrocyte precursor cells. 25 Moreover, Olig2 is critical for oligodendrocyte and motor neuron differentiation. 26 Thus, in this study, both Olig2 and A2B5 were assessed in differentiated cells. After immunocytochemistry, it was found that a high percentage of differentiated cells expressed special markers of . In addition, a high expression of Olig2 and PDGFRα genes also was seen in differentiated cells which was higher than expression of MBP and GFAP genes. In similar experiments, other sources of stem cells such as spermatogonia stem cells, endometrial stromal cells, mouse-induced pluripotent stem cells, and human-induced pluripotent stem cells also differentiated into oligodendrocyte. [27] [28] [29] [30] The results of these studies revealed that 88-94 percent of differentiated cells expressed Olig2, and 75-92 percent of them expressed A2B5.
Therefore, the comparison of these results show that by hADSCs differentiation, we can achieve a higher percentage of precursor oligodendrocyte cells.
One hypothesis could be that hADSCs can secrete high levels of neurotrophic factors, which could support the cell differentiation.
In this study, the mean absorbance value of the differentiated cells significantly increased as compared to control group; which could be due to the presence of growth factors in cell differentiation medium.
Another relevant finding of our study is that a less than 3 percentage of differentiated cells were only positive for GFAP which shows the efficiency of in vitro differentiation of hADSCs into oligodendrocyte cells.
Conclusion
Overall, the results of present study revealed that hADSCs are able to differentiate into oligodendrocyte precursor cells at a high level. Thus, due to the strong differentiation capacity of hADSCs and considering their ability to increase the neighboring cells viability through paracrine effects, it seems that hADSCs could be an ideal cell source for in vitro oligodendrocyte differentiation.
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